The transcriptional coactivator GCN5 from yeast (yGCN5) is a Histone AcetylTransferases (HATs) 1 that is essential for activation of target genes. GCN5 is a member of a large family of HATs which are conserved between yeast and humans. In order to understand the molecular mechanisms of histone/protein acetylation, a detailed kinetic analysis was performed. Bisubstrate kinetic analysis using acetyl-coenzyme A (AcCoA) 1 and an H3 histone synthetic peptide indicated that both substrates must bind to form a ternary complex prior to catalysis. Product inhibition studies revealed that the product CoA was a competitive inhibitor versus AcCoA.
revealed that residues contacting CoA in the active site are highly conserved. In addition, a biochemical study (18) of yGCN5 enzymatic activity had implicated the conserved Glutamic acid -173 as a general base catalyst in the GCN5 HAT reaction, deprotonating the ε-amino group of Lysine 14 in histone H3.
Elucidating the mechanism of HAT catalysis will provide a basis for understanding the link between histone acetylation and gene activation. In this study we have systematically determined the overall kinetic mechanism, developed methods for measuring substrate/product binding affinities (fluorescence anisotropy and equilibrium dialysis), and determined the order of substrate binding and the order of product release by employing the product inhibitors CoA and acetylated (Lys14Ac) H3 peptide, and the dead-end inhibitor desulfo-CoA. The results are consistent with a fully ordered Bi-Bi kinetic mechanism, where AcCoA is the first substrate to bind and CoA is the last product released.
Experimental Procedures
Materials. All chemicals were of the highest grade commercially available. Histone H3 peptide, ARTKQTARKSTGGKAPPKQLC and the corresponding acetylated H3 peptide (Lys14Ac), corresponding to the 20 amino-terminal residues of human histone H3 and an additional carboxy-terminal cysteine were synthesized by the Protein Chemistry Core Lab at The Baylor College of Medicine. Acetyl-CoA was purchased from Boeringer Mannheim. Calf thymus histones were purchased from Calbiochem. 
Expression and Purification. The catalytic domain (amino acids 99-262) of yGCN5 was recombinantly expressed by Isopropyl-Β-D-thiogalacto-pyranoside (IPTG) induction for 12 h at 25°C
and purified from BL21-DE3 bacteria as described previously (18, 19) . Following cation exchange chromatography on S-Sepharose, fractions (assessed by SDS-polyacrylamide gel electrophoresis) were pooled and concentrated and then subjected to size-exclusion chromatography on G-75 Sephadex. Purity was analyzed by SDS PAGE, and fractions concentrated and stored at -20 °C until use. Protein concentrations were determined by the method of Bradford (20).
Enzymatic Assays for yGCN5. yGCN5 histone acetyltransferase activity was monitored continuously using a Multiskan Ascent microplate reader (LabSystems, Franklin, MA) as previously described (19) . Briefly, the CoASH generated in the HAT reactions was continuously measured by using a coupled enzyme system with pyruvate dehydrogenase. The CoASHdependent oxidation of pyruvate is accompanied by the reduction of NAD to NADH, which was measured spectrophotometrically at 340 nm (ε 340 NADH = 6220 M -1 cm -1 ). The HAT assay reaction mixtures (70 µL) contained 0.2 mM NAD, 0.2 mM thiamine pyrophosphate (TPP), 5 mM MgCl 2 , 7 50 mM Bis-Tris, and 50 mM Tris and pH 7.5. All assays were performed at 25 °C and were initiated by the addition of yGCN5. The rates were analyzed continuously for up to 5 min and background rates resulting from the spontaneous formation of CoA were subtracted from the initial velocities derived from the yGCN5-catalyzed reactions. Under these conditions, the coupled enzyme reaction does not limit the observed initial velocities (19). Also, only the linear portion of the kinetic traces were used to determine the initial-rates. These were typically linear for up to 5
min. Stock solutions of the H3 peptide or acetylated (Lys14Ac) H3 peptide were prepared fresh daily in the presence of 5 mM DTT. Alternatively, yGCN5 activity was measured using (Eq. 5), or uncompetitive (Eq. 6) inhibition was observed, the data were fitted to the respective inhibition equations based on the algorithms defined by Cleland (21) using a nonlinear least squares analysis. where A is the anisotropy measured at a given concentration of yGCN5, and A free and A bound are the anisotropies of free and bound εCoA respectively. This simplified equation can be used when the dissociation constant is ≥ 10-fold higher than the fluorescent ligand concentration, since the concentration of yGCN5 bound to εCoA becomes negligible in comparison to the total yGCN5 concentration (22) .
Results

Effect of Ionic Strength on yGCN5
Catalyzed HAT Activity. Given the highly charged characteristic of the nucleosomal complex, it is likely that ionic strength will greatly influence the catalytic activity of these enzymes. Therefore, the effect of ionic strength on the yGCN5 HAT reaction was examined by varying NaCl concentrations between 0 and 1 M and the resulting HAT activity was monitored in the radioactive P81-filter binding assay as described in the methods. The resulting yGCN5 activity was plotted versus the log of the ionic strength and fitted to a line using least-squares analysis (Fig. 1) . A direct linear relationship between the log of the ionic strength and inactivation of yGCN5 HAT activity was observed. There was an approximate 7-fold decrease of yGCN5 HAT activity between 0.15 M NaCl and 1 M NaCl.
Bi-Substrate Kinetics. Yeast GCN5 catalyzes the transfer of an acetyl moiety from AcCoA to the ε-amino side chain of Lys 14 of histone H3 (Scheme 1). It was first necessary to determine the basic kinetic mechanism (sequential or ping-pong) utilized by yGCN5 before a detailed investigation into the order of substrate binding and the order of product release could be performed. CoA-dependent transferases are known to utilize one of two distinct mechanisms to catalyze acetyl group transfer. One mechanism involves acetyl transfer from CoA to an enzyme side chain nucleophile prior to transfer to the amine substrate (23) . In a subsequent step, the enzyme then transfers this acetyl group to the acceptor amine substrate. The alternative mechanism involves direct acetyl transfer from AcCoA to the amine substrate acceptor, without the formation of a covalent enzyme intermediate (24) . The latter mechanism requires that both substrates and enzyme must form a ternary complex before catalysis can occur. In a previous study (18) we performed a Bi-substrate kinetic analysis with core histone proteins (H3, H2A, H2B, and H4)
derived from calf thymus and demonstrated that yGCN5 utilizes a sequential (ternary complex) mechanism. Here, a synthetic H3 peptide (ARTKQTARKSTGGKAPPKQLC) was employed as a substrate in lieu of calf-thymus histones since this substrate provides a better defined system to analyze the steady-state kinetic parameters.
To distinguish between a ternary complex (sequential) mechanism and a ping-pong Table 1 . Employing acetylated (Lys14Ac) synthetic H3
peptide as a substrate for yGCN5, it was determined that Lysine 14 of H3 peptide is the only residue of H3 peptide acetylated. No other Lysine (K4, K9, or K18) of H3 peptide was found to be acetylated above background levels when using either the radioactive P81-filter binding assay or the coupled enzyme spectrophotometric assay (data not shown). This is an important result since acetylation at a secondary site to Lysine 14 of H3 peptide would significantly complicate the initial velocity kinetic analysis.
Several distinct kinetic mechanisms are possible for enzyme systems that employ two substrates and produce two products. Our previous study (18) combined with the Bi-substrate analysis described above have strongly argued against a ping-pong (covalent-intermediate) type mechanism and demonstrated that yGCN5 followed a sequential Bi Bi mechanism. The binding of substrates and release of products can be random, fully ordered, or a combination of both.
Product inhibition studies can easily distinguish among the various possibilities.
Product Inhibition. In order to distinguish among the various possible kinetic models for substrate binding and product release, the products of the yGCN5 catalyzed HAT reaction were used to inhibit the yGCN5 catalyzed HAT reaction. To correctly analyze product inhibition data, the reversibility of the yGCN5 catalyzed reaction was examined. This was accomplished by a HPLC assay using reversed phase chromatography to directly monitor the formation of deacetylated H3 peptide from a reaction of yGCN5, CoA and acetylated (Lys14Ac) H3 peptide.
Analysis of the time points from a reaction carried out at pH 7. This indicates that at high concentrations of AcCoA, the inhibition by CoA is overcome and the V max values approach identical levels. CoA was found to be a linear competitive inhibitor (Fig. 3) versus AcCoA at 100 µM H3 peptide, with a K is of 6.7 ± 5.1 µM, similar to the value obtained for (Fig. 2 ) the K m for AcCoA (4.5 ± 3.6 µM). The replot of the slopes from the double reciprocal plot as a function of [CoA] was linear and yielded similar inhibition constants (analysis not shown). These data indicated that AcCoA and CoA compete for the same form of yGCN5 and the same mutually exclusive binding site. In a sequential mechanism involving two substrates and two products, this requires that AcCoA and CoA bind to free enzyme, thus AcCoA is the first substrate to add and CoA is the last product to leave. In a complimentary experiment, CoA did not inhibit against H3 peptide when AcCoA was present at saturating levels (data not shown). These results are consistent with CoA and H3 peptide binding to different forms of yGCN5 and are consistent with the kinetic mechanism in which AcCoA binds first, followed by binding of H3 peptide and subsequent transfer of the acetyl group from AcCoA to H3 and an ordered release of products with acetylated (Lys14Ac) H3 peptide releasing prior to the release of CoA (Scheme 2).
To further demonstrate that H3 peptide and core histones operate through the same kinetic mechanism, CoA inhibition studies were carried out using calf thymus core histones as the amine nucleophile substrate (Fig. 4) . As with H3 peptide (Fig. 3 εCoA contains a fluorescent derivative of adenine (containing two additional carbon atoms) which has been utilized to study many ATP-, NAD-, and CoA-dependent enzymes (26) (27) (28) (29) (30) . Two separate x-ray structures of CoA and GCN5 complexes demonstrated that there are no significant interactions between GCN5 and the adenine moiety of CoA (15, 16) . We therefore reasoned that εCoA could be successfully employed as a relevant CoA analog. As expected, upon binding yGCN5, εCoA exhibited a change in fluorescence emission polarization (anisotropy). We used this change in polarization to generate a binding curve, and to determine the dissociation constant (Fig. 7) . Using this analysis, we calculated a dissociation constant (K d ) of 5.1 ± 1.1 µM. A control experiment in which excess AcCoA was added resulted in the loss of the change in fluorescence emission polarization (data not shown). The K d value is in excellent agreement with the K is of 6.7 µM obtained for CoA (Fig. 3) , suggesting that εCoA is a valid replacement for CoA in these binding studies. The dissociation constants for AcCoA and εCoA are listed in Table 1 .
Acetylated (Lys14Ac) H3 peptide as a Product Inhibitor.
To complete the product inhibition studies, the product inhibitor acetylated (Lys14Ac) H3 peptide was examined as an inhibitor versus both H3 peptide and AcCoA. As predicted by the kinetic model (Scheme 2), both effects were found to be noncompetitive (mixed-type), indicating that the substrate/inhibitor pairs bind to different enzyme forms and that there is a reversible connection between the two points of binding (Fig. 8) . Interestingly, the slope effects (reversible connection) were less dramatic, suggesting that the reversible connection is quite weak. Our observation that the reverse reaction is extremely slow (about 0.00002 s -1 ), ~100,000-fold lower than for the forward reaction (1.7 s -1 ), would provide a reasonable explanation for the weaker reversible connection. The steady-state kinetic inhibition parameters for acetylated (Lys14Ac) H3 peptide are summarized in Table 1 .
These results, in conjunction with the CoA and desulfo-CoA inhibition data, are consistent with yGCN5 catalyzed HAT activity following kinetic Scheme 2. (31) . It is well established that a double reciprocal plot analysis that generates an intersecting line pattern suggests a ternary-complex mechanism, and a parallel line pattern is characteristic of a ping-pong (covalent-intermediate) mechanism. This approach has been previously used to predict the behavior of other well characterized acetyltransferases (23, 24) . Here, the resulting Bi-substrate intersecting line-pattern with yGCN5 (Fig. 2) is consistent with a ternary-complex mechanism. These data are consistent with a direct attack of lysine on AcCoA. Though it is impossible to exclude the existence of a In this study, we employed a synthetic peptide substrate (ARTKQTARKSTGGKAPPKQL) corresponding to the amino-terminal 20 amino acids of histone H3. Previously, it was demonstrated that commercial preparations of calf thymus cores histones also generated an intersecting line-pattern from similar Bi-substrate kinetic analyses (18) .
Moreover, the k cat values obtained using either substrate are similar. Together, these results indicate that both the H3 peptide and H3 protein (within the core octamer) follow the same kinetic mechanism, and that synthetic H3 peptide is a valid and relevant substrate in detailed mechanistic studies. In fact, the synthetic peptide substrate affords many advantages over a heterogeneous preparation of histones derived from calf thymus. First, the synthetic H3 peptide is completely unacetylated. The acetylation state of histones derived from calf thymus is ill-defined and likely varies among preparations. Second, the non-enzymatic acetylation reaction rate is greatly reduced with H3 peptide since there are only four possible lysine acetylation sites compared to calf thymus histones which contain four core histones H3, H2A, H2B, H4 along with linker H1. Third, we are able to use the well defined product, synthetic acetylated (Lys14Ac) H3 peptide, as a product inhibitor for the yGCN5 catalyzed HAT reaction. These advantages have allowed us to completely define the kinetic mechanism, as described in Scheme 2
The recently solved structures (both x-ray and NMR) of GCN5 and GCN5 homologues have implicated the formation of a ternary complex of GCN5, AcCoA, and H3 peptide (15) (16) (17) .
The molecular models revealed two pronounced clefts that are roughly orthogonal to one another. interactions involve the pyrophosphate group and pantetheine arm of CoA. The crystal structure predicts that there is ample room to accommodate the acetyl-moiety of AcCoA. In fact, the carbonyl of the acetyl group would be positioned closer to both the nucleophile ε-amino group of Lysine 14 and the proposed general base Glutamic acid -173, which must deprotonate the ε-amino group of Lysine 14 prior to attack on the carbonyl carbon of AcCoA. Indeed, we had demonstrated previously that the conserved Glutamic acid -173 residue was acting as a general base (18) . This study revealed an ionization of a residue that must be unprotonated for activity (pK a of 8.3 ± 0.2). Using site-directed mutagenesis and pH activity profiles, the observed ionization was assigned to Glu-173. We concluded that Glu-173 was functioning as a general base, deprotonating the ε-amino group of Lysine 14 from histone H3. From later structural studies, it was discovered that two large hydrophobic clefts converged at the location of Glutamic acid -173. This hydrophobic environment surrounding Glutamic acid -173 is consistent with the observed elevated pK a (16, 18) .
Product Inhibition Studies.
The Bi-substrate kinetic analysis described here strongly suggests that a ternary complex mechanism is utilized by GCN5. To determine the order of substrate binding and the order of product release, product inhibition studies were undertaken.
The type of product inhibition observed is diagnostic for a particular kinetic scheme (31) .
Typically, one substrate and one product are varied at saturating or subsaturating levels of the other substrate, and the resulting double reciprocal plots indicate the type of inhibition. The two HAT reaction products, acetylated (Lys14Ac) H3 peptide and CoA, were employed as product inhibitors. The fully ordered mechanism of Scheme 2 was easily distinguished from other possible random mechanisms. Acetylated (Lys14Ac) H3 peptide was examined as an inhibitor versus both H3 peptide and AcCoA (Fig. 8) . As predicted by the kinetic model (Scheme 2), both effects were found to be noncompetitive (mixed-type), indicating that the substrate/inhibitor pairs bind to different enzyme forms and that there is a reversible connection between the two points of binding. Interestingly, the slope effects (reversible connection) were less dramatic, suggesting that the reversible connection is quite weak. Our observation that the reverse reaction is extremely slow (~0.00002 s -1 ) would provide a reasonable explanation for the weaker reversible connection. The product CoA exhibited pure competitive inhibition towards AcCoA (Fig 3) , indicating that AcCoA and CoA compete for the same enzyme form. In a sequential mechanism, this requires that acetylCoA and CoA bind to free enzyme, thus AcCoA is the first substrate to add and CoA is the last product to be released (Scheme 2). As predicted by the kinetic model, CoA does not inhibit against H3 when AcCoA is present at saturating levels (data not shown). Consistent with CoA acting as a pure competitive inhibitor, we utilized the CoA derivative desulfo-CoA in our steady-state inhibition studies and found that desulfo-CoA also acts as a pure competitive inhibitor with respect to acetyl-CoA (Fig. 5) . Desulfo-CoA is a dead-end inhibitor since it forms a non-productive complex. Taken together with the fact that acetylated (Lys14Ac) H3 peptide is a linear noncompetitive (mixed) inhibitor against both H3 peptide and AcCoA (Fig. 8 ) strongly suggest that AcCoA is the first to bind yGCN5 followed by H3 peptide. After transfer of the acetyl-moiety from AcCoA to H3 peptide in the ternary complex, acetylated (Lys14Ac) H3 peptide must leave first followed by the subsequent release of CoA (Scheme 2). The data suggest that if H3 peptide is capable of binding to yGCN5 it does so only weakly.
Given our kinetic and biochemical evidence that this highly conserved family of GCN5 HATs utilize a fully ordered Bi Bi kinetic mechanism, it is likely that binding of AcCoA to yGCN5 induces a conformational change that then optimizes the pocket for H3 peptide binding. Consistent with this, a recently solved structure of a GCN5-related N-acetyltransferase (GNAT) family member, serotonin N-acetyltransfease complexed with a Bi-substate analogue, predicts that binding of AcCoA will induce a conformational change that exposes the binding site for the amine substrate serotonin (32). This is in good agreement with the kinetic mechanism of serotonin Nacetyltransferase proposed by Cole and colleagues (33) . As we have demonstrated for yGCN5, serotonin N-acetyltransferase was shown to obey an ordered Bi Bi mechanism. Moreover, the crystal structure of the Tetrahymena GCN5:CoA:H3 peptide ternary complex suggest that the binding of H3 peptide is dependent on AcCoA binding first (16) (Fig. 7) . This value is in good agreement with the K is of 6.7 µM for CoA (Fig. 3) determined in the inhibition studies. By equilibrium dialysis, a dissociation constant (K d ) of 8.5 ± 2.6 µM was determined for AcCoA binding to free enzyme (Fig. 6) the data were fitted to a covalent intermediate (ping-pong) mechanism, the sum of the squares of the residuals were >100-fold larger than that for the sequential mechanism which was > 2-fold greater than an equilibrium ordered-mechanism (described in methods). The experiment was performed in triplicate with a representative plot displayed. 
